Clinical Trials Logo

Clinical Trial Summary

HTL0018318 is a selective muscarinc M1 agonist. This study is a phase I, open label, randomised, crossover, single dose, trial in healthy volunteers to compare the relative bioavailability of HTL0018318 when given by oral aqueous solution and in capsule formulation.


Clinical Trial Description

n/a


Study Design


Related Conditions & MeSH terms

  • Bioavailability and Pharmacokinetics

NCT number NCT02958696
Study type Interventional
Source Heptares Therapeutics Limited
Contact
Status Completed
Phase Phase 1
Start date October 2016
Completion date January 2017

See also
  Status Clinical Trial Phase
Completed NCT01991509 - Safety and Bioavailability of IV and SC LBR-101 Phase 1